WHI Premarin Results Support Short-Term Use; Breast Cancer Reduction May Be Bright Spot

Data from the estrogen-only arm of Women's Health Initiative show increased risk of stroke, no effect on heart disease, and a trend towards reduced breast cancer. NIH says the results parallel current clinical recommendations that hormone therapy be used at the lowest dose for the shortest period of time.